THE PROSTATE CANCER FOUNDATION named 24 Young Investigator Award winners. Members of the Class of 2016 were selected from a pool of 128 applicants from 77 institutions across 15 countries. Successful proposals included the use of genomics to predict prognosis and personalize treatments, as well as immunological approaches. The projects predominantly concentrated on treatment-resistant prostate... […]
THE NCI SURGERY BRANCH resumed enrollment of patients in clinical protocols evaluating immunotherapy as a treatment for patients with metastatic cancer.
RAJESH GARG was named president and CEO of Cancer Treatment Centers of America. He also is a member of the company’s national board of directors. At McKinsey & Company, Garg worked with many health care companies developing strategic growth, operations, and business development programs and initiatives. Garg earned an M.D. from Stanford Medical School, a... […]
THE LEUKEMIA & LYMPHOMA SOCIETY and the American Society of Hematology will collaborate to promote new treatments for acute myeloid leukemia, which the organizations say has not seen a change in the standard of care for more than 40 years. They plan to educate both patients and healthcare practitioners of the importance and availability of... […]
THE PANCREATIC CANCER ACTION NETWORK, along with advocates and survivors, gathered on Capitol Hill this week to urge Congress to fund federal cancer research. “To ensure Congress continues to make cancer research funding a priority, we need even more committed individuals to join our efforts,” said Julie Fleshman, president and CEO of the Pancreatic Cancer... […]
ST. JUDE’S Department of Pathology received accreditation to the ISO15189 standard under an accreditation program through the College of American Pathologists. St. Jude is the first children’s hospital in the nation to be accredited under this program. The accreditation is based on the standard for laboratories’ technical competence, management, and improvement. It focuses on improved... […]
MAYO CLINIC will collaborate with Kiyatec Inc. on technology platforms for ovarian cancer care. Mayo Clinic is enrolling patients in a study that uses patient-derived xenografts to generate living tumor samples specific to each enrolled ovarian cancer patient. The study assesses whether those samples can help determine which chemotherapy is most effective to treat that... […]
TAKEDA Pharmaceutical Company Ltd. and M2Gen plan to collaborate with ORIEN to generate broad genomic data from cancer patients. Under the agreement, Takeda will help build M2Gen’s Oncology Research Information Exchange Network Avatar Research Program based on the Total Cancer Care Protocol, a prospective observational study enrolling patients with various cancers, and access information generated... […]
MIAMI CANCER INSTITUTE at Baptist Health South Florida received a 220-ton proton therapy cyclotron. The institute offers the only proton therapy center in South Florida, and plans to offer treatment beginning in 2017. “The arrival of the cyclotron signifies the beginning of the most sophisticated cancer treatment technology in the history of our organization,” said... […]
KETY DURON joined City of Hope as chief human resources and diversity officer. Duron will provide executive and strategic oversight for all of City of Hope’s human resources initiatives. Duron was vice president of human resources at Stanford Health Care. Before that, she served in a variety of human resources leadership roles at UCLA Health... […]
